Delivery Order SPE2DB22D3301-SPE2DB25FY3RS

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.55 delivery order is for the medication Mounjaro, a 2.5 mg/0.5 ml pen with a 0.5 ml volume. The contract is a firm fixed price, non-set-aside award with a period of performance through June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $2,899.99 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro 15 mg/0.5 ml pen. The contract has an ultimate completion date of May 22, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
This federal contract award, valued at $3,265.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Mounjaro, a 5 mg/0.5 ml medication pen, with a performance period extending through April 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award, valued at $8,138.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen 0.5 ml, with a completion date of May 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 ml pen with a 0.5 ml dosage. The contract has a firm fixed price of $1,369.56 and a completion date of June 25, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,054.15 firm fixed-price delivery order is for the medication MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 7, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $4,359.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,249,563 units of the medication Mounjaro 2.5 mg/0.5 ml pen, with a completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $1,904.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml, with a performance period ending on April 11, 2025. This delivery order is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mounjaro 12.5 mg/0.5 ml pens. The $2,034.92 firm fixed-price delivery order is for products to be delivered by May 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,578.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) to support military treatment facilities and programs. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 13, 2024. The contract is not designated as a set-aside....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY3RS
    Delivery Order

This federal contract award, valued at $2,485.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 2.5 mg/0.5 ml pen 0.5 ml, with a performance period through April 2025.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The current contract award does not have a set-aside designation, indicating open competition.

Generated 7/22/25, 10:03 AM